230 related articles for article (PubMed ID: 24535703)
1. A clinicopathological review of 33 patients with vulvar melanoma identifies c-KIT as a prognostic marker.
Heinzelmann-Schwarz VA; Nixdorf S; Valadan M; Diczbalis M; Olivier J; Otton G; Fedier A; Hacker NF; Scurry JP
Int J Mol Med; 2014 Apr; 33(4):784-94. PubMed ID: 24535703
[TBL] [Abstract][Full Text] [Related]
2. Satellitosis and CD117 immunohistochemical expression correlates with poor outcome in thick vulvar melanoma.
Salcedo-Hernandez RA; Lino-Silva LS; Isla-Ortiz D; Posada-Torres JA; Chanona-Vilchis JG; Perez-Montiel MD; Aguilar-Romero JM; Dominguez-Rodriguez JA; Herrera-Gomez A
G Ital Dermatol Venereol; 2017 Feb; 152(1):8-12. PubMed ID: 27377140
[TBL] [Abstract][Full Text] [Related]
3. KIT mutations and CD117 overexpression are markers of better progression-free survival in vulvar melanomas.
Dias-Santagata D; Selim MA; Su Y; Peng Y; Vollmer R; Chłopik A; Tell-Marti G; Paral KM; Shalin SC; Shea CR; Puig S; Fernandez-Figueras MT; Biernat W; Ryś J; Marszalek A; Hoang MP
Br J Dermatol; 2017 Nov; 177(5):1376-1384. PubMed ID: 28734009
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of c-KIT in vulvar cancer: bringing this molecular marker from bench to bedside.
de Melo Maia B; Lavorato-Rocha AM; Rodrigues IS; Baiocchi G; Cestari FM; Stiepcich MM; Chinen LT; Carvalho KC; Soares FA; Rocha RM
J Transl Med; 2012 Jul; 10():150. PubMed ID: 22839358
[TBL] [Abstract][Full Text] [Related]
5. Tumor Thickness and Mitotic Rate Robustly Predict Melanoma-Specific Survival in Patients with Primary Vulvar Melanoma: A Retrospective Review of 100 Cases.
Nagarajan P; Curry JL; Ning J; Piao J; Torres-Cabala CA; Aung PP; Ivan D; Ross MI; Levenback CF; Frumovitz M; Gershenwald JE; Davies MA; Malpica A; Prieto VG; Tetzlaff MT
Clin Cancer Res; 2017 Apr; 23(8):2093-2104. PubMed ID: 27864417
[No Abstract] [Full Text] [Related]
6. Vulvar melanoma at the M. D. Anderson Cancer Center: 25 years later.
Verschraegen CF; Benjapibal M; Supakarapongkul W; Levy LB; Ross M; Atkinson EN; Bodurka-Bevers D; Kavanagh JJ; Kudelka AP; Legha SS
Int J Gynecol Cancer; 2001; 11(5):359-64. PubMed ID: 11737466
[TBL] [Abstract][Full Text] [Related]
7. Prognostic role of tumoral PDL1 expression and peritumoral FoxP3+ lymphocytes in vulvar melanomas.
Chłopik A; Selim MA; Peng Y; Wu CL; Tell-Marti G; Paral KM; Shalin SC; Kraft S; Hsu CK; Shea CR; Puig S; Fernandez-Figueras MT; Biernat W; Ryś J; Marszalek A; Hoang MP
Hum Pathol; 2018 Mar; 73():176-183. PubMed ID: 29307625
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of treatment and prognosis of 59 cases of vulvar melanoma].
Yuan GW; Li XG; Li N; Yao HW; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2020 Jun; 55(6):395-401. PubMed ID: 32842246
[No Abstract] [Full Text] [Related]
9. Melanoma of the Vulva and Vagina: Surgical Management and Outcomes Based on a Clinicopathologic Reviewof 68 Cases.
Sinasac SE; Petrella TM; Rouzbahman M; Sade S; Ghazarian D; Vicus D
J Obstet Gynaecol Can; 2019 Jun; 41(6):762-771. PubMed ID: 30391279
[TBL] [Abstract][Full Text] [Related]
10. Construction and validation of a prognostic nomogram for primary vulvar melanoma: a SEER population-based study.
Zhou H; Zou X; Li H; Chen L; Cheng X
Jpn J Clin Oncol; 2020 Dec; 50(12):1386-1394. PubMed ID: 32776099
[TBL] [Abstract][Full Text] [Related]
11. Vulvar lichen sclerosus and squamous cell carcinoma: a cohort, case control, and investigational study with historical perspective; implications for chronic inflammation and sclerosis in the development of neoplasia.
Carlson JA; Ambros R; Malfetano J; Ross J; Grabowski R; Lamb P; Figge H; Mihm MC
Hum Pathol; 1998 Sep; 29(9):932-48. PubMed ID: 9744309
[TBL] [Abstract][Full Text] [Related]
12. Malignant Melanoma of Vulva and Vagina: A Histomorphological Review and Mutation Analysis--A Single-Center Study.
Rouzbahman M; Kamel-Reid S; Al Habeeb A; Butler M; Dodge J; Laframboise S; Murphy J; Rasty G; Ghazarian D
J Low Genit Tract Dis; 2015 Oct; 19(4):350-3. PubMed ID: 26225944
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of treatment, prognostic factors, and survival in 198 vulvar melanoma patients: Implications for clinical practice.
Boer FL; Ten Eikelder MLG; van Geloven N; Kapiteijn EH; Gaarenstroom KN; Hughes G; Nooij LS; Jozwiak M; Tjiong MY; de Hullu JMA; Galaal K; van Poelgeest MIE
Gynecol Oncol; 2021 Apr; 161(1):202-210. PubMed ID: 33514483
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of epithelial disorders adjacent to invasive vulvar carcinomas.
Rouzier R; Morice P; Haie-Meder C; Lhomme C; Avril MF; Duvillard P; Castaigne D
Gynecol Oncol; 2001 Jun; 81(3):414-9. PubMed ID: 11371131
[TBL] [Abstract][Full Text] [Related]
15. Mucosal melanoma: clinical, histological and c-kit gene mutational profile of 86 French cases.
Cinotti E; Chevallier J; Labeille B; Cambazard F; Thomas L; Balme B; Leccia MT; D'Incan M; Vercherin P; Douchet C; Rubegni P; Perrot JL
J Eur Acad Dermatol Venereol; 2017 Nov; 31(11):1834-1840. PubMed ID: 28543798
[TBL] [Abstract][Full Text] [Related]
16. Clinically identifying women with vulvar lichen sclerosus at increased risk of squamous cell carcinoma: a case-control study.
Jones RW; Sadler L; Grant S; Whineray J; Exeter M; Rowan D
J Reprod Med; 2004 Oct; 49(10):808-11. PubMed ID: 15568404
[TBL] [Abstract][Full Text] [Related]
17. p53 and p16 expression profiles in vulvar cancer: a translational analysis by the Arbeitsgemeinschaft Gynäkologische Onkologie Chemo and Radiotherapy in Epithelial Vulvar Cancer study group.
Woelber L; Prieske K; Eulenburg C; Oliveira-Ferrer L; de Gregorio N; Klapdor R; Kalder M; Braicu I; Fuerst S; Klar M; Strauss HG; Beckmann M; Meier W; Ignatov A; Mustea A; Jueckstock J; Schmidt G; Bauerschlag D; Hellriegel M; Canzler U; Petry KU; Kommoss S; Hantschmann P; Heubner M; Mahner S; Burandt E
Am J Obstet Gynecol; 2021 Jun; 224(6):595.e1-595.e11. PubMed ID: 33453182
[TBL] [Abstract][Full Text] [Related]
18. Association of Vulvar Melanoma with Lichen Sclerosus.
Hieta N; Kurki S; Rintala M; Söderlund J; Hietanen S; Orte K
Acta Derm Venereol; 2019 Mar; 99(3):339-340. PubMed ID: 30521058
[No Abstract] [Full Text] [Related]
19. Vulvar malignant melanoma associated with human papillomavirus DNA: report of two cases and review of literature.
Rohwedder A; Philips B; Malfetano J; Kredentser D; Carlson JA
Am J Dermatopathol; 2002 Jun; 24(3):230-40. PubMed ID: 12140440
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors for local recurrence of squamous cell carcinoma of the vulva: A systematic review.
Te Grootenhuis NC; Pouwer AW; de Bock GH; Hollema H; Bulten J; van der Zee AGJ; de Hullu JA; Oonk MHM
Gynecol Oncol; 2018 Mar; 148(3):622-631. PubMed ID: 29137809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
